Biocon Boosts Biosimilars In Australia With Sandoz Partnership

Five-Year Exclusive Marketing Deal Will Cover Indian Firm’s Trastuzumab And Bevacizumab

 
• By David Wallace
  
Australian flag with vial and syringe
Biocon and Sandoz have struck a biosimilars deal in Australia • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business